Press release
Catheter-Related Bloodstream Infection (CRBSI) Drugs Market is expected to reach US$ 2.8 billion by 2033 | Major Companies - Hikma Pharmaceuticals PLC, Pfizer, Inc., SteriMax, Baxter
Catheter-Related Bloodstream Infection (CRBSI) Drugs Market
The Global Catheter-Related Bloodstream Infection (CRBSI) Drugs Market size reached US$ 1.6 billion in 2024 and is expected to reach US$ 2.8 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.
DataM Intelligence has published a new research report on "Catheter-Related Bloodstream Infection (CRBSI) Drugs Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/catheter-related-bloodstream-infection-drugs-market?sz
The Catheter-Related Bloodstream Infection (CRBSI) Drugs Market refers to the global industry focused on the development, production, and commercialization of antimicrobial therapies used to treat bloodstream infections caused by intravascular catheters. These drugs include antibiotics, antifungals, and antimicrobial lock solutions designed to eliminate pathogens and prevent complications. Market growth is driven by rising hospital-acquired infections, increasing use of central venous catheters, expanding critical care services, and growing demand for effective infection control and antimicrobial stewardship strategies worldwide.
Recent Key Developments of United States:
✅ December 2025: Antibiotic lock solutions saw broader hospital implementation, supporting precision medicine approaches.
✅ November 2025: US pharmaceutical leaders advanced next-generation antimicrobial coatings for catheters, targeting biofilm resistance amid rising hospital-acquired infections.
✅ October 2025: Regulatory nods boosted AI-integrated diagnostics for faster CRBSI detection, enhancing real-time monitoring in major hospitals.
✅ September 2025: Investments surged in antibiotic-lock therapies, driven by immune-compromised patient growth and CLABSI prevention protocols.
Recent Key Developments of Japan:
✅ December 2025: Japanese facilities increased use of catheter lock solutions for CRBSI management, emphasizing biofilm-resistant materials.
✅ November 2025: Japanese firms ramped up nanotechnology-based antimicrobial coatings, aligning with national infection prevention priorities.
✅ October 2025: Adoption of advanced diagnostic tools accelerated, supported by precision medicine initiatives for bloodstream infections.
✅ September 2025: Heightened R&D in sepsis management therapeutics gained momentum, fueled by government-backed antimicrobial innovations.
List of the Key Players in the Catheter-Related Bloodstream Infection (CRBSI) Drugs Market:
Hikma Pharmaceuticals PLC
Zhejiang Novus Pharmaceuticals Co., Ltd.
Pfizer, Inc.
SteriMax
Baxter
Fresenius Kabi USA
Merck & Co., Inc.
Xellia Pharmaceuticals
AdvaCare Pharma
Avet Pharmaceuticals Inc.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/catheter-related-bloodstream-infection-drugs-market?sz
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Segments Covered in the Catheter-Related Bloodstream Infection (CRBSI) Drugs Market:
By Causative Organisms: Bacterial Infections, Fungal Infection, Viral and Parasitic Infections.
By Drug Class: Antibiotics, Antifungals, Antivirals, Others.
By Route of Administration: Oral, Injectable.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=catheter-related-bloodstream-infection-drugs-market
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Catheter-Related Bloodstream Infection (CRBSI) Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Catheter-Related Bloodstream Infection (CRBSI) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Catheter-Related Bloodstream Infection (CRBSI) Drugs Market in 2026?
◆ What is the projected growth rate of the Catheter-Related Bloodstream Infection (CRBSI) Drugs Market through 2034?
◆ Who are the key players in the Catheter-Related Bloodstream Infection (CRBSI) Drugs Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Catheter-Related Bloodstream Infection (CRBSI) Drugs Market is expected to reach US$ 2.8 billion by 2033 | Major Companies - Hikma Pharmaceuticals PLC, Pfizer, Inc., SteriMax, Baxter here
News-ID: 4395031 • Views: …
More Releases from DataM Intelligence 4Market Research
Synovial Sarcoma Treatment Market is expected to reach US$ 1646.61 million by 20 …
Market Size and Growth:
The Global Synovial Sarcoma Treatment Market size reached US$ 832.47 million in 2023 and is expected to reach US$ 1646.61 million by 2031, growing with a CAGR of 8.9% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "Synovial Sarcoma Treatment Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status…
VR/AR Technology for Healthcare Market is expected to reach US$ 12.14 billion by …
Market Size and Growth:
The Global VR/AR Technology for Healthcare Market size reached US$ 3.75 billion in 2023 and is expected to reach US$ 12.14 billion by 2031, growing with a CAGR of 15.8% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "VR/AR Technology for Healthcare Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business…
Hemostatic Agents Market is expected to reach US$ 4.15 billion by 2032 | Major C …
Market Size and Growth:
The Global Hemostatic Agents Market size reached US$ 3.01 billion in 2024 and is expected to reach US$ 4.15 billion by 2032, growing at a CAGR of 4.2% during the forecast period 2025-2032.
The Hemostatic Agents Market refers to the global industry focused on products and materials designed to stop bleeding during surgical procedures, trauma, or emergency care. These agents include topical powders, dressings, foams, and gels that…
PARP Inhibitors Market is expected to reach US$ 6.64 billion by 2031 | Major Com …
Market Size and Growth:
The Global PARP Inhibitors Market size reached US$ 3.53 billion in 2023 and is expected to reach US$ 6.64 billion by 2031, growing at a CAGR of 8.3% during the forecast period 2024-2031.
The PARP inhibitors Market refers to the global industry focused on developing, manufacturing, and commercializing drugs that inhibit poly (ADP-ribose) polymerase (PARP) enzymes. These targeted therapies are primarily used in oncology to treat cancers with…
More Releases for Infection
Growing Hospital-Acquired Infection Rates Boost Demand For Infection Prevention …
The Infection Prevention Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Infection Prevention Market?
In the past few years, there has been a consistent increase in the size of the infection prevention market. It is predicted that this market…
Prominent Infection Prevention Market Trend for 2025: Strategic Staffing Innovat …
What Are the Projected Growth and Market Size Trends for the Infection Prevention Market?
The infection prevention market is expected to grow from $43.4 billion in 2024 to $45.01 billion in 2025, reflecting a CAGR of 3.7%. Growth drivers include increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, technological advancements, and globalization.
The Infection Prevention market is expected to grow to $52.2 billion by 2029 at a CAGR of 3.8%, driven…
Yeast Infection Treatment Market Report 2024 - Yeast Infection Treatment Market …
"The Business Research Company recently released a comprehensive report on the Global Yeast Infection Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The yeast infection…
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications.
The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few…
Infection Surveillance Solutions Market: Empowering Infection Prevention | BD, B …
Allied Market Research analysts have recently introduced a new research study titled "Infection Surveillance Solutions Market- Global Outlook and Forecast 2023-2030." The report offers detailed insights and highlights key players in the industry, including Atlas Medical Software, Becton, Dickinson and Company, Baxter International, GOJO Industries, Deb Group, RL Solutions, HyGreen, Wolters Kluwer, Premier, and Truven Health Analytics. This comprehensive study provides in-depth and clear analysis, encompassing market definitions, classifications, manufacturing…
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026.
The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,…
